SCHEMBL7000249

SCHEMBL7000249

CC1(C)OC(c2ccc(S(N)(=O)=O)cc2F)=C(c2cccc(C(F)(F)F)c2)C1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
CA1 P00915 5/20 0.38
CA2 P00918 5/20 0.38
CA9 Q16790 4/20 0.38
AKR1C3 P42330 2/20 0.37
AKR1C2 P52895 2/20 0.37
CA12 O43570 2/20 0.36
PTGS2 P35354 4/20 0.36
PTGS1 P23219 3/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
ELANE P08246 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997353 0.91 PTGS2 (0.43) AKR1C3AKR1C2PTGS2PTGS1ELANE
SCHEMBL7001723 0.88 PTGS2 (0.48) CA1CA2CA9CA12PTGS2
SCHEMBL6996080 0.86 KIF11 (0.44) KDM4EGAACA1CA2CA9
SCHEMBL6993214 0.86 PTGS2 (0.42) CA1CA2CA9CA12PTGS2
SCHEMBL6997219 0.86 CA1 (0.41) CA1CA2CA9CA12PTGS2
SCHEMBL7003323 0.83 PTGS2 (0.46) CA1CA2CA9CA12PTGS2
SCHEMBL6997443 0.83 AKR1C3 (0.38) AKR1C3AKR1C2PTGS1
SCHEMBL3228727 0.82 PTGS2 (0.46) CA1CA2CA9CA12PTGS2
SCHEMBL3231323 0.82 PTGS2 (0.41) CA1CA2CA9CA12PTGS2
SCHEMBL7002103 0.82 AKR1C3 (0.38) AKR1C3AKR1C2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109799-B1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORP (KR) 2003-12-17 EP claimed
US-6492416-B1 TREATING INFLAMMATION AND ASSOCIATED DISORDERS PACIFIC CORPORATION (KR) 2002-12-10 US claimed
EP-1109799-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2001-06-27 EP claimed
WO-2000061571-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2000-10-19 WO claimed
EP-1109799-B1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORP (KR) 2003-12-17 EP disclosed
US-6492416-B1 TREATING INFLAMMATION AND ASSOCIATED DISORDERS PACIFIC CORPORATION (KR) 2002-12-10 US disclosed
EP-1109799-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2001-06-27 EP disclosed
WO-2000061571-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2000-10-19 WO disclosed